Search Count: 46
 |
C-Terminal Bromodomain Of Human Brd2 With 5-(1-Benzyl-4-Chloro-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, PE4, A1IBV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, PE4, A1IBV
 |
N-Terminal Bromodomain Of Human Brd4 With (5-(4-Chloro-1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2024-06-26 Classification: TRANSCRIPTION Ligands: EDO, A1IB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-06-26
Ligands: EDO, A1IB5
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Ethane-1,2-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-11-08 Classification: TRANSCRIPTION Ligands: EDO, ZTT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-11-08
Ligands: EDO, ZTT
 |
C-Terminal Bromodomain Of Human Brd2 With 1,3-Dimethyl-5-(1-((Tetrahydro-2H-Pyran-4-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)Pyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: NUB, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: NUB, MES
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-5-(1-((1-Acetylpiperidin-3-Yl)Methyl)-5-Bromo-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: EDO, MES, I0U |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: EDO, MES, I0U
 |
N-Terminal Bromodomain Of Human Brd4 With (S)-5-(1-((1-(1-Isopropylpiperidine-4-Carbonyl)Piperidin-3-Yl)Methyl)-1H-Benzo[D]Imidazol-2-Yl)-1,3-Dimethylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2023-10-18 Classification: TRANSCRIPTION Ligands: I0Z |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-18
Ligands: I0Z
 |
N-Terminal Bromodomain Of Human Brd4 With (1R,1'R)-7,7'-(Pentane-1,5-Diylbis(Oxy))Bis(1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.38 Å Release Date: 2023-10-04 Classification: TRANSCRIPTION Ligands: ZTY, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-10-04
Ligands: ZTY, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With I-Bet282
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2021-10-13 Classification: TRANSCRIPTION Ligands: EDO, UYK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-13
Ligands: EDO, UYK
 |
C-Terminal Bromodomain Of Human Brd2 With 6-Benzyl-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: UL5, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: UL5, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-N5-Cyclopropyl-N3-Methyl-2-Oxo-1-(1-Phenylethyl)-1,2-Dihydropyridine-3,5-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.28 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULH
 |
C-Terminal Bromodomain Of Human Brd2 With Oxabicyclo(Hexan-6-Yl)-N2-Methyl-6-((S)-1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, PE4, ULN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, PE4, ULN
 |
C-Terminal Bromodomain Of Human Brd2 With 6-((S)-Hydroxy(Phenyl)Methyl)-N2-Methyl-N4-((1S,2S)-2-Methylcyclopropyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULK
 |
C-Terminal Bromodomain Of Human Brd2 With (S)-N4-Cyclopropyl-N2-Methyl-6-(1-Phenylethyl)Pyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: ULE, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: ULE, EDO
 |
C-Terminal Bromodomain Of Human Brd2 With N4-((1R,5S,6R)-3-Oxabicyclo[3.1.0]Hexan-6-Yl)-6-((S)-Methoxy(Phenyl)Methyl)-N2-Methylpyridine-2,4-Dicarboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2021-07-21 Classification: NUCLEAR PROTEIN Ligands: EDO, ULQ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-07-21
Ligands: EDO, ULQ
 |
C-Terminal Bromodomain Of Human Brd2 With Gsk973
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2020-10-21 Classification: TRANSCRIPTION Ligands: EDO, 1PG, QC8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-10-21
Ligands: EDO, 1PG, QC8
 |
C-Terminal Bromodomain Of Human Brd2 With N-(2-(1H-Imidazol-4-Yl)Ethyl)-4-Acetamido-3-(Benzyloxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2020-07-29 Classification: TRANSCRIPTION Ligands: PEG, EDO, QB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-29
Ligands: PEG, EDO, QB5
 |
N-Terminal Bromodomain Of Human Brd4 With N-(2-(1H-Imidazol-4-Yl)Ethyl)-4-Acetamido-3-(Benzyloxy)Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2020-07-29 Classification: TRANSCRIPTION Ligands: QB5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-07-29
Ligands: QB5
 |
Crystal Structure Of Human Atad2 Bromodomain In Complex With N-(4-Bromo-3-(3-Methylpyrrolidin-1-Yl)Sulfonyl)Phenyl)-2-(-4-Cyclopropyl-4-Methyl-2,5-Dioxoimidazolidin-1-Yl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2020-05-06 Classification: TRANSCRIPTION Ligands: SO4, EDO, OJH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-05-06
Ligands: SO4, EDO, OJH
 |
N-Terminal Bromodomain Of Human Brd2 With 5-(4-(4-Fluorophenyl)-1H-Imidazol-5-Yl)-1-Methylpyridin-2(1H)-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.26 Å Release Date: 2020-02-19 Classification: TRANSCRIPTION Ligands: SO4, NUQ, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-02-19
Ligands: SO4, NUQ, EDO
 |
N-Terminal Bromodomain Of Human Brd4 With 1-((1-Acetylpiperidin-4-Yl)Methyl)-2-(4-Hydroxy-3,5-Dimethylphenyl)-N-Methyl-1H-Benzo[D]Imidazole-5-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2020-01-15 Classification: TRANSCRIPTION Ligands: NUW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2020-01-15
Ligands: NUW, EDO